CEPHEID

Develops, manufactures, and markets molecular systems and tests for institutions to perform sophisticated genetic testing for organisms and genetic-based diseases
Silver member
Products Covid-19
Close

Covid-19 CEPHEID

Clinical Laboratory

SARS CoV-2/Flu/RSV Test
Xpert Xpress CoV-2/Flu/RSV plus

The Xpert Xpress CoV-2/Flu/RSV plus enables actionable detection of SARS-CoV-2 in as little as 25 minutes, with results for all four pathogens in just 36 minutes. It offers a robust design with three distinct gene targets for SARS-CoV-2: N2, E, RdRP to offer broader coverage against mutations.
More details

SARS-CoV-2 Test
Xpert® Xpress SARS-CoV-2

The Xpert® Xpress SARS-CoV-2 is a rapid, near-patient test for the detection of the 2019 novel coronavirus that causes COVID-19 that leverages the design principles of Cepheid’s current Xpert® Xpress Flu/RSV cartridge technology, in which multiple regions of the viral genome are targeted. The test can provide rapid detection of the current pandemic coronavirus SARS-CoV-2 in as soon as 30 minutes for positive results with less than a minute of hands on time to prepare the sample.
More details

SARS-CoV-2/Flu/RSV Test
Xpert® Xpress SARS-CoV-2/Flu/RSV

The Xpert® Xpress SARS-CoV-2/Flu/RSV four-in-one test is expected to deliver qualitative detection of SARS-CoV-2, Flu A, Flu B and RSV from a single patient sample. The test is designed for use on any of Cepheid's more than 25,000 GeneXpert® Systems placed worldwide, with results expected in as little as 35 minutes.
More details
FaceBook Twitter Google+ Linked in

SARS CoV-2/Flu/RSV Test

Model: Xpert Xpress CoV-2/Flu/RSV plus
SARS CoV-2/Flu/RSV Test

Description:

The Xpert Xpress CoV-2/Flu/RSV plus enables actionable detection of SARS-CoV-2 in as little as 25 minutes, with results for all four pathogens in just 36 minutes. It offers a robust design with three distinct gene targets for SARS-CoV-2: N2, E, RdRP to offer broader coverage against mutations.

Features

Features

• Actionable detection of SARS-CoV-2 in as little as 25 minutes, with results for all four pathogens in just 36 minutes.
• Robust design with three distinct gene targets for SARS-CoV-2: N2, E, RdRP to offer broader coverage against mutations.
• Rapid sample to answer provides actionable results from a single sample with less than one minute of hands-on time.
• Standardization of results between the central lab and decentralized testing sites.

Send A Message To This Supplier

* Required Information
* Email
To
CEPHEID (SARS CoV-2/Flu/RSV Test)
* Message

Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions